SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TGAN
Ambrx Biopharma, Inc. (AMAM)
Company Research
Source: GlobeNewswire
NEW YORK, Feb. 10, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Ambrx Biopharma, Inc. (NASDAQ: AMAM)’s sale to Johnson & Johnson for $28.00 per share in cash. If you are an Ambrx shareholder, click here to learn more about your rights and options. Harpoon Therapeutics, Inc. (NASDAQ: HARP)’s sale to Merck for $23.00 per share in cash. If you are a Harpoon shareholder, click here to learn more about your rights and options. Juniper Networks, Inc. (NYSE: JNPR)’s sale to Hewlett Packard for $40.00 per share. If you are a Juniper shareholder, click here to learn more about your rights and options. Transphorm, Inc. (NASDAQ: TGAN)’s sale to Renesas Electronics Corporation for $5.10 per share in cash. If you are a Transphorm shareholder, click here to learn more about your rights and options.
Show less
Read more
Impact Snapshot
Event Time:
AMAM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMAM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMAM alerts
High impacting Ambrx Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
AMAM
News
- Ambrx Shareholders Approve Acquisition by Johnson & JohnsonGlobeNewswire
- Is Ambrx Biopharma Inc. (AMAM) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, JNPR, INBX, RYZBPR Newswire
- AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAMBusiness Wire
- Lifshitz Law PLLC Announces Investigations of AMAM, HARP, AXNX, and FGHAccesswire
AMAM
Sec Filings
- 3/8/24 - Form S-8
- 3/8/24 - Form S-8
- 3/8/24 - Form S-8
- AMAM's page on the SEC website